|
Jul 29
|
Amneal (AMRX) is an Incredible Growth Stock: 3 Reasons Why
|
|
Jul 29
|
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
|
|
Jul 29
|
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
|
|
Jul 29
|
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
|
|
Jul 28
|
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
|
|
Jul 28
|
2 Reasons to Avoid AMRX and 1 Stock to Buy Instead
|
|
Jul 21
|
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
|
|
Jul 21
|
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
|
|
Jul 18
|
Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada
|
|
Jul 9
|
Amneal to Report Second Quarter 2025 Results on August 5, 2025
|
|
Jun 30
|
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
|
|
Jun 26
|
5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call
|
|
Jun 12
|
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
|
|
May 15
|
Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
|
|
Apr 17
|
Even though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 years
|
|
Apr 3
|
Amneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.
|
|
Apr 1
|
Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma
|
|
Feb 13
|
Although Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) insiders have sold lately, they have the highest ownership with 51% stake
|